MX2021013447A - Composiciones y procedimientos para el tratamiento de enfermedades oculares. - Google Patents
Composiciones y procedimientos para el tratamiento de enfermedades oculares.Info
- Publication number
- MX2021013447A MX2021013447A MX2021013447A MX2021013447A MX2021013447A MX 2021013447 A MX2021013447 A MX 2021013447A MX 2021013447 A MX2021013447 A MX 2021013447A MX 2021013447 A MX2021013447 A MX 2021013447A MX 2021013447 A MX2021013447 A MX 2021013447A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- methods
- ocular diseases
- treatment
- disclosure relates
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 208000022873 Ocular disease Diseases 0.000 title abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000000017 hydrogel Substances 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente divulgación se refiere a composiciones y procedimientos para el tratamiento de enfermedades oculares con antibióticos. En particular, la divulgación se refiere a composiciones de hidrogel que contienen antibióticos y que no nublan la visión y que tienen un tiempo de contacto prolongado en el ojo y no interfieren con la cicatrización de heridas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962842995P | 2019-05-03 | 2019-05-03 | |
PCT/US2020/030691 WO2020227002A1 (en) | 2019-05-03 | 2020-04-30 | Compositions and methods for treatment of ocular diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021013447A true MX2021013447A (es) | 2022-02-11 |
Family
ID=70861542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021013447A MX2021013447A (es) | 2019-05-03 | 2020-04-30 | Composiciones y procedimientos para el tratamiento de enfermedades oculares. |
Country Status (9)
Country | Link |
---|---|
US (2) | US11376214B2 (es) |
EP (1) | EP3962452A1 (es) |
JP (1) | JP7334266B2 (es) |
KR (2) | KR102649858B1 (es) |
CN (1) | CN114025742A (es) |
CA (1) | CA3139060A1 (es) |
IL (1) | IL287802B1 (es) |
MX (1) | MX2021013447A (es) |
WO (1) | WO2020227002A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10945858B2 (en) * | 2010-09-03 | 2021-03-16 | Globus Medical, Inc. | Expandable interspinous process fixation device |
GB202008853D0 (en) * | 2020-06-11 | 2020-07-29 | Univ Birmingham | Fluid gel compositions |
GB202008857D0 (en) * | 2020-06-11 | 2020-07-29 | Univ Birmingham | Fluid gel compositions |
CN112587475B (zh) * | 2020-12-18 | 2022-09-13 | 华熙生物科技股份有限公司 | 一种载药凝胶及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6620927B2 (en) * | 2001-02-22 | 2003-09-16 | Anika Therapeutics, Inc. | Thiol-modified hyaluronan |
CA2703807C (en) * | 2010-05-12 | 2017-10-24 | Molly S. Shoichet | Enhanced stability of inverse thermal gelling composite hydrogels |
US10137199B2 (en) | 2013-05-14 | 2018-11-27 | Biotime, Inc. | Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione |
US9782345B2 (en) * | 2013-10-17 | 2017-10-10 | Jade Therapeutics, Inc. | Ocular composition and method |
WO2019046834A1 (en) | 2017-09-01 | 2019-03-07 | Pmidg, Llc | FUNCTIONALIZED AND RETICULATED POLYMERS |
CN118126415A (zh) | 2017-09-19 | 2024-06-04 | 香港科技大学 | 生物可相容材料以及用于制备和使用所述生物可相容材料的方法 |
-
2020
- 2020-04-30 EP EP20728846.5A patent/EP3962452A1/en active Pending
- 2020-04-30 CA CA3139060A patent/CA3139060A1/en active Pending
- 2020-04-30 WO PCT/US2020/030691 patent/WO2020227002A1/en unknown
- 2020-04-30 CN CN202080044610.5A patent/CN114025742A/zh active Pending
- 2020-04-30 IL IL287802A patent/IL287802B1/en unknown
- 2020-04-30 KR KR1020217039722A patent/KR102649858B1/ko active IP Right Grant
- 2020-04-30 MX MX2021013447A patent/MX2021013447A/es unknown
- 2020-04-30 US US16/863,753 patent/US11376214B2/en active Active
- 2020-04-30 KR KR1020247008519A patent/KR20240038152A/ko active Application Filing
- 2020-04-30 JP JP2021565092A patent/JP7334266B2/ja active Active
-
2022
- 2022-05-27 US US17/827,154 patent/US20220287961A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP7334266B2 (ja) | 2023-08-28 |
US20220287961A1 (en) | 2022-09-15 |
CA3139060A1 (en) | 2020-11-12 |
KR102649858B1 (ko) | 2024-03-20 |
US11376214B2 (en) | 2022-07-05 |
WO2020227002A1 (en) | 2020-11-12 |
IL287802A (en) | 2022-01-01 |
CN114025742A (zh) | 2022-02-08 |
EP3962452A1 (en) | 2022-03-09 |
US20200345634A1 (en) | 2020-11-05 |
KR20240038152A (ko) | 2024-03-22 |
JP2022530837A (ja) | 2022-07-01 |
KR20220004753A (ko) | 2022-01-11 |
IL287802B1 (en) | 2024-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021013447A (es) | Composiciones y procedimientos para el tratamiento de enfermedades oculares. | |
MX2020006128A (es) | Inhibidores de la proteina de activacion de fibroblastos. | |
MX2023007212A (es) | Formulaciones de pulverizacion de epinefrina. | |
WO2020132661A3 (en) | Inhibitors of fibroblast activation protein | |
AU2018236629A8 (en) | Hydrogel patch | |
WO2018208793A8 (en) | S-NITROSOGLUTATHIOME INHIBITORS (GSNO) AND GSNO REDUCTASE USEFUL IN THERAPY | |
MX2019001633A (es) | Proteina derivada de la seda para el tratamiento de la inflamacion. | |
EP4378535A3 (en) | Antibiotic formulations for lower back pain | |
WO2019157495A3 (en) | Methods for preventing and/or treating bone loss conditions by modulating irisin | |
BR112017015387A2 (pt) | composição em gel tópica, método de tratamento de uma infecção da pele, composição em gel oftálmica, e, método de tratamento de uma afecção infecciosa do olho ou pálpebra | |
MX2022000310A (es) | Inhibidores de proteina bcl-2. | |
PH12021550621A1 (en) | Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness | |
MX2022006073A (es) | Metodos para utilizar anticuerpos anti-trem2. | |
MX2021002006A (es) | Tratamiento del cancer de mama triple negativo con inhibicion dirigida del factor de crecimiento transformante beta (tgf-b). | |
JOP20200253A1 (ar) | تركيبات وطرق لعلاج الحثل البقعي | |
MX355853B (es) | Composicion oftalmica para el tratamiento de infeccion ocular. | |
MX2020003534A (es) | Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares. | |
MX2021002652A (es) | Uso de inhibidores de caseina-cinasa 1 para el tratamiento de enfermedades vasculares. | |
WO2019040105A3 (en) | COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES | |
ZA202106519B (en) | Caspase inhibitors and methods of use thereof | |
PH12021550372A1 (en) | The use of alpha-2-adrenergic receptor agonists for improving vision | |
WO2020128070A3 (de) | Kollagenhydrolysat zur verwendung gegen hautkrankheiten und darmkrankheiten | |
WO2020109233A3 (en) | Trmt2a inhibitors for use in the treatment of polyglutamine diseases | |
MX2017007207A (es) | Tratamiento de afecciones oculares mediante el uso de celulas progenitoras. | |
SI3720428T1 (sl) | Oftalmični lokalni sestavek, ki vsebuje dobesilno kislino za zdravljenje bolezni posteriornega očesnega segmenta |